Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD

BMC Psychiatry

Volumn 11, Issue , 2011, Pages

  Lee, James ^a   Grizenko, Natalie ^a,b   Bhat, Venkataramana ^a,b   Sengupta, Sarojini ^b   Polotskaia, Anna ^a,b   Joober, Ridha ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; CENTRAL STIMULANT AGENT;

ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DECREASED APPETITE; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFECT; DRUG RESPONSE; EUPHORIA; HABIT; HEADACHE; HUMAN; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; NERVOUS MOVEMENT; NIGHTMARE; PRONENESS TO CRYING; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SADNESS; SIDE EFFECT; STARES A LOT; STOMACH PAIN; TALKS LESS; TIC; TREATMENT OUTCOME; UNINTERESTED; ADULT; ATTITUDE TO HEALTH; CLINICAL TRIAL; DRUG TOXICITY; HOSPITALIZATION; PARENT; PSYCHOLOGICAL ASPECT; TEACHING;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; ATTITUDE TO HEALTH; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CROSS-OVER STUDIES; DRUG TOXICITY; HUMANS; METHYLPHENIDATE; PARENTS; SEVERITY OF ILLNESS INDEX; TEACHING; TREATMENT OUTCOME;

EID: 79954616438     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-11-70     Document Type: Article

References (31)

1. Polanczyk G, de Lima M, Horta B, Biederman J, Rohde L. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. American Journal of Psychiatry 2007, 164:942. 10.1176/appi.ajp.164.6.942, 17541055.
2. Remschmidt H. Global consensus on ADHD/HKD. Eur Child Adolesc Psychiatry 2005, 14:127-137. 10.1007/s00787-005-0439-x, 15959658.
3. Jensen PS, Kettle L, Roper MT, Sloan MT, Dulcan MK, et al. Are stimulants overprescribed? Treatment of ADHD in four U.S. communities. J Am Acad Child Adolesc Psychiatry 1999, 38:797-804. 10.1097/00004583-199907000-00008, 10405496.
4. Jureidini J. Does the International Consensus Statement on ADHD leave room for healthy scepticism?. Eur Child Adolesc Psychiatry 2002, 11:240. author reply 241-242.
5. Kupfer DJ. The Consensus Development Panel. National Institutes of Health Consensus Development Conference statement: diagnosis and treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). Journal of the American Academy of Child and Adolescent Psychiatry 2000, 39:182-193. 10.1097/00004583-200002000-00018, 10673829.
6. Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 1997, 36:85S-121S.
7. Elia J, Ambrosini PJ, Rapoport JL. Treatment of attention-deficit-hyperactivity disorder. N Engl J Med 1999, 340:780-788. 10.1056/NEJM199903113401007, 10072414.
8. Wigal T, Swanson JM, Regino R, Lerner MA, Soliman I, et al. Stimulant medications for the treatment of ADHD: Efficacy and limitations. Mental Retardation and Developmental Disabilities Research Reviews 1999, 5:215-224.
9. Efron D, Jarman F, Barker M. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics 1997, 100:662-666. 10.1542/peds.100.4.662, 9310521.
10. Greenhill LL, Swanson JM, Vitiello B, Davies M, Clevenger W, et al. Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Am Acad Child Adolesc Psychiatry 2001, 40:180-187. 10.1097/00004583-200102000-00012, 11211366.
11. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, et al. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996, 35:409-432. 10.1097/00004583-199604000-00008, 8919704.
12. Barkley RA, McMurray MB, Edelbrock CS, Robbins K. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics 1990, 86:184-192.
13. Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, et al. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics 2003, 112:e404. 10.1542/peds.112.5.e404, 14595084.
14. Rapport M, Denney C, DuPAUL G, Gardner M. Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children. Journal of the American Academy of Child & Adolescent Psychiatry 1994, 33:882-893. 10.1097/00004583-199407000-00015, 21539491.
15. Tannock R, Schachar R, Carr R, Chajczyk D, Logan G. Effects of methylphenidate on inhibitory control in hyperactive children. Journal of Abnormal Child Psychology 1989, 17:473-491. 10.1007/BF00916508, 2681316.
16. Zeiner P, Bryhn G, Bjercke C, Truyen K, Strand G. Response to methylphenidate in boys with attention-deficit hyperactivity disorder. Acta paediatrica 1999, 88:298-303. 10.1111/j.1651-2227.1999.tb01100.x, 10229041.
17. Schweitzer J, Lee D, Hanford R, Zink C, Ely T, et al. Effect of methylphenidate on executive functioning in adults with attention-deficit/hyperactivity disorder: normalization of behavior but not related brain activity. Biological psychiatry 2004, 56:597-606. 10.1016/j.biopsych.2004.07.011, 15476690.
18. Pataki CS, Carlson GA, Kelly KL, Rapport MD, Biancaniello TM. Side effects of methylphenidate and desipramine alone and in combination in children. J Am Acad Child Adolesc Psychiatry 1993, 32:1065-1072. 10.1097/00004583-199309000-00028, 8407753.
19. Fine S, Johnston C. Drug and placebo side effects in methylphenidate-placebo trial for attention deficit hyperactivity disorder. Child Psychiatry Hum Dev 1993, 24:25-30. 10.1007/BF02353715, 8404241.
20. Fischer M, Newby RF. Assessment of Stimulant Response in ADHD Children Using a Refined Multimethod Clinical Protocol. Journal of Clinical Child Psychology 1991, 20:232-244.
21. Solanto M. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behavioural Brain Research 94:127-152.
22. Berridge C, Devilbiss D, Andrzejewski M, Arnsten A, Kelley A, et al. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biological psychiatry 2006, 60:1111-1120. 10.1016/j.biopsych.2006.04.022, 16806100.
23. Diagnostic and statistical manual of mental disorders. 1994, Washington, DC: American Psychiatric Association.
24. Diagnostic Interview Schedule for Children, version IV. 1998, National Institute of Mental Health, Accessed March 1, 2004.
25. Wechsler D. Manual for the Wechsler Intelligence Scale for Children-Third Edition. 1991, San Antonio, TX: Psychological Corporation.
26. Achenbach T. Manual for the Child Behavior Checklist/4-18 and 1991 Profile. 1991, University of Vermont DoP, editor. Burlington.
27. Conners CK, Sitarenios G, Parker JD, Epstein JN. The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol 1998, 26:257-268. 10.1023/A:1022602400621, 9700518.
28. Conners CK, Sitarenios G, Parker JD, Epstein JN. Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol 1998, 26:279-291. 10.1023/A:1022606501530, 9700520.
29. Barkley RA. A review of stimulant drug research with hyperactive children. The Journal of Child Psychology and Psychiatry 1977, 18:137-165.
30. Perrin J, Stein M, Amler R, Blondis T, Feldman H, et al. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 2001, 108:1033-1044.
31. Schachar RJ, Tannock R, Cunningham C, Corkum PV. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. J Am Acad Child Adolesc Psychiatry 1997, 36:754-763. 10.1097/00004583-199706000-00011, 9183129.